How big is the oncology molecular diagnostic industry?

The global oncology molecular diagnostic market size is expected to increase USD 8.50 billion by 2034 from USD 2.45 billion in 2023. Read More

What will be the CAGR of the global oncology molecular diagnostic industry?

The global oncology molecular diagnostic market will register a growth rate of 11% between 2024 and 2034. Read More

Who are the prominent players operating in the oncology molecular diagnostic market?

The major players operating in the oncology molecular diagnostic market are Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific Inc., Illumina, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Genomic Health, Inc., Myriad Genetics, Inc., Agilent Technologies, Inc., Siemens Healthineers, Danaher Corporation (Cepheid), Sysmex Corporation, Hologic, Inc., Guardant Health, Inc., Foundation Medicine, Inc. and others. Read More

Which are the driving factors of the oncology molecular diagnostic market?

The driving factors of the oncology molecular diagnostic market are the expanding applications and emphasis on early cancer detection. Read More

Which region will lead the global oncology molecular diagnostic market?

North America region will lead the global oncology molecular diagnostic market during the forecast period 2024 to 2034. Read More

Oncology Molecular Diagnostic Market Size, Share, and Trends 2024 to 2033

Oncology Molecular Diagnostic Market (By Type: Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Other Cancer; By Technology: PCR, In Situ Hybridization, INAAT, Chips and Microarrays, Mass Spectrometry, Sequencing, TMA, Others; By Product: Instruments, Reagents, Others ) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Last Updated : January 2024
Report Code : 3677
Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Oncology Molecular Diagnostic Market

5.1. COVID-19 Landscape: Oncology Molecular Diagnostic Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Oncology Molecular Diagnostic Market, By Type

8.1. Oncology Molecular Diagnostic Market Revenue and Volume, by Type, 2024-2034

8.1.1 Breast Cancer

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Prostate Cancer

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Colorectal Cancer

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

8.1.4. Cervical Cancer

8.1.4.1. Market Revenue and Volume Forecast (2021-2034)

8.1.5. Liver Cancer

8.1.5.1. Market Revenue and Volume Forecast (2021-2034)

8.1.6. Lung Cancer

8.1.6.1. Market Revenue and Volume Forecast (2021-2034)

8.1.7. Lung Cancer

8.1.7.1. Market Revenue and Volume Forecast (2021-2034)

8.1.8. Blood Cancer

8.1.8.1. Market Revenue and Volume Forecast (2021-2034)

8.1.9. Kidney Cancer

8.1.9.1. Market Revenue and Volume Forecast (2021-2034)

8.1.10. Other Cancer

8.1.10.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Oncology Molecular Diagnostic Market, By February

9.1. Oncology Molecular Diagnostic Market Revenue and Volume, by February, 2024-2034

9.1.1. Cathode

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Anode

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

9.1.3. Electrolyte

9.1.3.1. Market Revenue and Volume Forecast (2021-2034)

9.1.4. Separator

9.1.4.1. Market Revenue and Volume Forecast (2021-2034)

9.1.5. Others

9.1.5.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Oncology Molecular Diagnostic Market, By March

10.1. Oncology Molecular Diagnostic Market Revenue and Volume, by March, 2024-2034

10.1.1. Consumer

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Automotive

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Industrial

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

10.1.4. Cheese

10.1.4.1. Market Revenue and Volume Forecast (2021-2034)

10.1.5. Others

10.1.5.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Oncology Molecular Diagnostic Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.1.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.1.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.1.4.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.1.4.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.1.5.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.1.5.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.2.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.2.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.2.4.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.2.4.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.2.5.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.2.5.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.2.6.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.2.6.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.2.7.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.2.7.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.3.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.3.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.3.4.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.3.4.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.3.5.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.3.5.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.3.6.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.3.6.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.3.7.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.3.7.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.4.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.4.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.4.4.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.4.4.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.4.5.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.4.5.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.4.6.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.4.6.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.4.7.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.4.7.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.5.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.5.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.5.4.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.5.4.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)

11.5.5.2. Market Revenue and Volume Forecast, by February (2021-2034)

11.5.5.3. Market Revenue and Volume Forecast, by March (2021-2034)

Chapter 12. Company Profiles

12.1. Roche Diagnostics

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Abbott Laboratories

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Thermo Fisher Scientific Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Illumina, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Qiagen N.V.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Bio-Rad Laboratories, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Genomic Health, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Myriad Genetics, Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Agilent Technologies, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Siemens Healthineers

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

We use cookies to improve your experience

Oncology Molecular Diagnostic Market Report By 2034

List of Contents